148 related articles for article (PubMed ID: 21821730)
1. Improved bioavailability of epoxyeicosatrienoic acids reduces TP-receptor agonist-induced tension in human bronchi.
Senouvo FY; Tabet Y; Morin C; Albadine R; Sirois C; Rousseau E
Am J Physiol Lung Cell Mol Physiol; 2011 Nov; 301(5):L675-82. PubMed ID: 21821730
[TBL] [Abstract][Full Text] [Related]
2. Epoxyeicosatrienoic acids function as selective, endogenous antagonists of native thromboxane receptors: identification of a novel mechanism of vasodilation.
Behm DJ; Ogbonna A; Wu C; Burns-Kurtis CL; Douglas SA
J Pharmacol Exp Ther; 2009 Jan; 328(1):231-9. PubMed ID: 18836067
[TBL] [Abstract][Full Text] [Related]
3. Relationship between bradykinin-induced relaxation and endogenous epoxyeicosanoid synthesis in human bronchi.
Tabet Y; Sirois M; Sirois C; Rizcallah E; Rousseau É
Am J Physiol Lung Cell Mol Physiol; 2013 Apr; 304(8):L562-9. PubMed ID: 23418089
[TBL] [Abstract][Full Text] [Related]
4. Role of thromboxane A2 in bradykinin-induced human isolated small bronchi contraction.
Molimard M; Martin CA; Naline E; Hirsch A; Advenier C
Eur J Pharmacol; 1995 May; 278(1):49-54. PubMed ID: 7545124
[TBL] [Abstract][Full Text] [Related]
5. Thromboxane prostanoid receptor activation amplifies airway stretch-activated contractions assessed in perfused intact bovine bronchial segments.
Hernandez JM; Janssen LJ
J Pharmacol Exp Ther; 2011 Oct; 339(1):248-56. PubMed ID: 21768224
[TBL] [Abstract][Full Text] [Related]
6. Epoxyeicosatrienoic acid relaxing effects involve Ca2+-activated K+ channel activation and CPI-17 dephosphorylation in human bronchi.
Morin C; Sirois M; Echave V; Gomes MM; Rousseau E
Am J Respir Cell Mol Biol; 2007 May; 36(5):633-41. PubMed ID: 17237191
[TBL] [Abstract][Full Text] [Related]
7. Enhanced airway smooth muscle cell thromboxane receptor signaling via activation of JNK MAPK and extracellular calcium influx.
Lei Y; Cao Y; Zhang Y; Edvinsson L; Xu CB
Eur J Pharmacol; 2011 Jan; 650(2-3):629-38. PubMed ID: 21036122
[TBL] [Abstract][Full Text] [Related]
8. Inhibition of soluble epoxide hydrolase by trans-4- [4-(3-adamantan-1-yl-ureido)-cyclohexyloxy]-benzoic acid is protective against ischemia-reperfusion injury.
Chaudhary KR; Abukhashim M; Hwang SH; Hammock BD; Seubert JM
J Cardiovasc Pharmacol; 2010 Jan; 55(1):67-73. PubMed ID: 19834332
[TBL] [Abstract][Full Text] [Related]
9. EET displays anti-inflammatory effects in TNF-alpha stimulated human bronchi: putative role of CPI-17.
Morin C; Sirois M; Echave V; Gomes MM; Rousseau E
Am J Respir Cell Mol Biol; 2008 Feb; 38(2):192-201. PubMed ID: 17872494
[TBL] [Abstract][Full Text] [Related]
10. Pharmacological evidence for thromboxane receptor heterogeneity--implications for the eye.
Krauss AH; Woodward DF; Burk RM; Gac TS; Gibson LL; Protzman CE; Abbass F; Marshall K; Senior J
J Ocul Pharmacol Ther; 1997 Aug; 13(4):303-12. PubMed ID: 9261766
[TBL] [Abstract][Full Text] [Related]
11. Soluble epoxide hydrolase contamination of specific catalase preparations inhibits epoxyeicosatrienoic acid vasodilation of rat renal arterioles.
Gauthier KM; Olson L; Harder A; Isbell M; Imig JD; Gutterman DD; Falck JR; Campbell WB
Am J Physiol Renal Physiol; 2011 Oct; 301(4):F765-72. PubMed ID: 21753077
[TBL] [Abstract][Full Text] [Related]
12. The role of prostaglandin E and thromboxane-prostanoid receptors in the response to prostaglandin E2 in the aorta of Wistar Kyoto rats and spontaneously hypertensive rats.
Tang EH; Jensen BL; Skott O; Leung GP; Feletou M; Man RY; Vanhoutte PM
Cardiovasc Res; 2008 Apr; 78(1):130-8. PubMed ID: 18093985
[TBL] [Abstract][Full Text] [Related]
13. Heterogeneity of thromboxane A2 (TP-) receptors: evidence from antagonist but not agonist potency measurements.
Tymkewycz PM; Jones RL; Wilson NH; Marr CG
Br J Pharmacol; 1991 Mar; 102(3):607-14. PubMed ID: 1364826
[TBL] [Abstract][Full Text] [Related]
14. Docosahexaenoic acid and eicosapentaenoic acid strongly inhibit prostanoid TP receptor-dependent contractions of guinea pig gastric fundus smooth muscle.
Xu K; Shimizu M; Murai C; Fujisawa M; Ito D; Saitoh N; Nakagome Y; Yamashita M; Murata A; Oikawa S; Ou G; Yoshioka K; Obara K; Tanaka Y
Pharmacol Res Perspect; 2022 Jun; 10(3):e00952. PubMed ID: 35466586
[TBL] [Abstract][Full Text] [Related]
15. EET-dependent potentiation of pulmonary arterial pressure: sex-different regulation of soluble epoxide hydrolase.
Kandhi S; Qin J; Froogh G; Jiang H; Luo M; Wolin MS; Huang A; Sun D
Am J Physiol Lung Cell Mol Physiol; 2015 Dec; 309(12):L1478-86. PubMed ID: 26498250
[TBL] [Abstract][Full Text] [Related]
16. Adenosine A2A receptor modulates vascular response in soluble epoxide hydrolase-null mice through CYP-epoxygenases and PPARγ.
Nayeem MA; Pradhan I; Mustafa SJ; Morisseau C; Falck JR; Zeldin DC
Am J Physiol Regul Integr Comp Physiol; 2013 Jan; 304(1):R23-32. PubMed ID: 23152114
[TBL] [Abstract][Full Text] [Related]
17. Pharmacological characterization of thromboxane and prostanoid receptors in human isolated urinary bladder.
Palea S; Toson G; Pietra C; Trist DG; Artibani W; Romano O; Corsi M
Br J Pharmacol; 1998 Jul; 124(5):865-72. PubMed ID: 9692770
[TBL] [Abstract][Full Text] [Related]
18. Soluble epoxide hydrolase inhibitor trans-4-[4-(3-adamantan-1-yl-ureido)-cyclohexyloxy]-benzoic acid is neuroprotective in rat model of ischemic stroke.
Shaik JS; Ahmad M; Li W; Rose ME; Foley LM; Hitchens TK; Graham SH; Hwang SH; Hammock BD; Poloyac SM
Am J Physiol Heart Circ Physiol; 2013 Dec; 305(11):H1605-13. PubMed ID: 24043255
[TBL] [Abstract][Full Text] [Related]
19. Prostaglandin E2 inhibits mast cell-dependent bronchoconstriction in human small airways through the E prostanoid subtype 2 receptor.
Säfholm J; Manson ML; Bood J; Delin I; Orre AC; Bergman P; Al-Ameri M; Dahlén SE; Adner M
J Allergy Clin Immunol; 2015 Nov; 136(5):1232-9.e1. PubMed ID: 25962903
[TBL] [Abstract][Full Text] [Related]
20. [Inhibitory effects of AA-2414, a thromboxane (Tx) A2 receptor antagonist, on U-46619-, prostaglandin (PG) D2- and 9 alpha, 11 beta PGF2-induced contractions of guinea pig tracheas and isolated human bronchi].
Itoh Y; Shindoh J; Horiba M; Kohno S; Ohata K; Ashida Y; Takagi K
Arerugi; 1993 Nov; 42(11):1670-6. PubMed ID: 8279967
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]